137 related articles for article (PubMed ID: 29302376)
1. Clinicopathological Significance of Large Tumor Suppressor (
Son MW; Song GJ; Jang SH; Hong SA; Oh MH; Lee JH; Baek MJ; Lee MS
J Gastric Cancer; 2017 Dec; 17(4):363-373. PubMed ID: 29302376
[TBL] [Abstract][Full Text] [Related]
2. Expression of large tumour suppressor (LATS) kinases modulates chemotherapy response in advanced non-small cell lung cancer.
Luo SY; Kwok HH; Yang PC; Ip MS; Minna JD; Lam DC
Transl Lung Cancer Res; 2020 Apr; 9(2):294-305. PubMed ID: 32420069
[TBL] [Abstract][Full Text] [Related]
3. Expression of LATS family proteins in ovarian tumors and its significance.
Xu B; Sun D; Wang Z; Weng H; Wu D; Zhang X; Zhou Y; Hu W
Hum Pathol; 2015 Jun; 46(6):858-67. PubMed ID: 25841306
[TBL] [Abstract][Full Text] [Related]
4. Molecular Alterations and Expression Dynamics of LATS1 and LATS2 Genes in Non-Small-Cell Lung Carcinoma.
Malik SA; Khan MS; Dar M; Hussain MU; Shah MA; Shafi SM; Mudassar S
Pathol Oncol Res; 2018 Apr; 24(2):207-214. PubMed ID: 28434174
[TBL] [Abstract][Full Text] [Related]
5. Comparative expression of zebrafish lats1 and lats2 and their implication in gastrulation movements.
Chen CH; Sun YH; Pei DS; Zhu ZY
Dev Dyn; 2009 Nov; 238(11):2850-9. PubMed ID: 19842174
[TBL] [Abstract][Full Text] [Related]
6. Outcome in serous ovarian cancer is not associated with LATS expression.
Montavon C; Stricker GR; Schoetzau A; Heinzelmann-Schwarz V; Jacob F; Fedier A
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2737-2749. PubMed ID: 31586262
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
Takahashi Y; Miyoshi Y; Takahata C; Irahara N; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2005 Feb; 11(4):1380-5. PubMed ID: 15746036
[TBL] [Abstract][Full Text] [Related]
8. Association analysis between SNPs in LATS1 and LATS2 and non-cardia gastric cancer.
Ma LC; Tian XY; Gao F; Dong WJ; Dang T; Jia YB
BMC Gastroenterol; 2020 May; 20(1):155. PubMed ID: 32423384
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and Clinicopathological Significance of Transducer-Like Enhancer of Split 1 Expression in Gastric Cancer.
Lee JH; Son MW; Kim KJ; Oh MH; Cho H; Lee HJ; Jang SH; Lee MS
J Gastric Cancer; 2016 Mar; 16(1):21-7. PubMed ID: 27104023
[TBL] [Abstract][Full Text] [Related]
10. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
11. [Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
Liu SH; Hou XY; Zhang XX; Liu GW; Xin FJ; Wang JG; Zhang DL; Wang DS; Lu Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1059-1066. PubMed ID: 33212554
[No Abstract] [Full Text] [Related]
12. High Yes-associated protein 1 with concomitant negative LATS1/2 expression is associated with poor prognosis of advanced gastric cancer.
Kim E; Ahn B; Oh H; Lee YJ; Lee JH; Lee Y; Kim CH; Chae YS; Kim JY
Pathology; 2019 Apr; 51(3):261-267. PubMed ID: 30819540
[TBL] [Abstract][Full Text] [Related]
13. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
14. Different effects of p53 protein overexpression on the survival of gastric cancer patients according to Lauren histologic classification: a retrospective study.
Kim KW; Kim N; Choi Y; Kim WS; Yoon H; Shin CM; Park YS; Lee DH; Park YS; Ahn SH; Park DJ; Kim HH; Lee HS; Kim JW; Kim JW; Lee KW; Chang W; Park JH; Lee YJ; Lee KH; Kim YH
Gastric Cancer; 2021 Jul; 24(4):844-857. PubMed ID: 33598811
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of the large tumor suppressor genes in Japanese lung cancer.
Sasaki H; Hikosaka Y; Kawano O; Yano M; Fujii Y
Oncol Lett; 2010 Mar; 1(2):303-307. PubMed ID: 22966299
[TBL] [Abstract][Full Text] [Related]
16. A single copy of large tumor suppressor 1 or large tumor suppressor 2 is sufficient for normal hematopoiesis.
Li ZG; Fu XM; Chai CY; Sun FF; Xiao FF; Huang YX; Yao K; Chen JP; Hou Y
Chin Med J (Engl); 2020 Aug; 133(16):1943-1951. PubMed ID: 32826458
[TBL] [Abstract][Full Text] [Related]
17. [Expression of LATS mRNA in mantle cell lymphoma and its clinical significance].
Yu Z; Yi S; Zhang Y; Li Z; Qiu L
Zhonghua Yi Xue Za Zhi; 2015 Oct; 95(40):3285-8. PubMed ID: 26815349
[TBL] [Abstract][Full Text] [Related]
18. LATS tumor suppressor: a new governor of cellular homeostasis.
Visser S; Yang X
Cell Cycle; 2010 Oct; 9(19):3892-903. PubMed ID: 20935475
[TBL] [Abstract][Full Text] [Related]
19. Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway.
Huntoon CJ; Nye MD; Geng L; Peterson KL; Flatten KS; Haluska P; Kaufmann SH; Karnitz LM
Cancer Res; 2010 Nov; 70(21):8642-50. PubMed ID: 20841485
[TBL] [Abstract][Full Text] [Related]
20. Loss of large tumor suppressor 1 promotes growth and metastasis of gastric cancer cells through upregulation of the YAP signaling.
Zhang J; Wang G; Chu SJ; Zhu JS; Zhang R; Lu WW; Xia LQ; Lu YM; Da W; Sun Q
Oncotarget; 2016 Mar; 7(13):16180-93. PubMed ID: 26921249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
